Молекулярная медицина
233 статей · 5 журналов
Журналы подкатегории (5)
- Molecular Therapy Advances · Elsevier (80)
- Biochimica et Biophysica Acta: Molecular Basis of Disease · Elsevier (60)
- Trends in Molecular Medicine · Elsevier (49)
- Mitochondrion · Elsevier (44)
- EMBO Molecular Medicine · Springer Nature (0)
- Vascular-device Suitcordance: a tri-ecological framework for eco-rebalancing
- The unfolded protein response in precision oncology: from mechanisms to therapeutic opportunities
- What determines skin wound regeneration or scar healing?
- Predicting outcomes in oncogenic HPV infection: are we there yet?
- What determines premalignant fate? A tale of stromal–epithelial crosstalk
- Mesenchymal stem cells in bone regeneration: an organellar perspective
- Disarming CH25H to clear α-synuclein
- Advances in modeling chromosomal aberrations to recapitulate genomic rearrangements
- Degradation-coupled antibody conjugates for precision cancer therapy
- Compartmentalized coenzyme A and ferroptosis vulnerability in PKAN and CoPAN
- Rethinking nonsense suppression therapies in inherited retinal diseases
- Rethinking kidney cancer through the lens of microphthalmia (MiT)/transcription factor E (TFE) Biology
- Advisory Board and Contents
- Plasma signals reveal targetable tumor-promoting lung niches
- Formicitoxins: membrane-targeting antifungal peptides from carpenter ant venoms
- Is endometriosis a progressive disease?
- Muscle-to-CNS signaling in physiological homeostasis, aging, and disease
- Ubiquitin-specific peptidase 22 targeting: Tumor cell erasure, immune engine unleashed
- Targeting the NAD+–PARP1–XRCC1 axis in ALS
- Targeting the hyaluronic acid–CD44 axis in hepatocellular carcinoma
- Mitochondrial dysfunction in cerebrovascular diseases
- Subscription and Copyright Information
- Trends at 50: a mission that matters
- Mesoscale tissue states in fibrosis: from pathway targeting to state-directed therapy
- Beyond the skin: how skin-derived signals shape systemic immunity
- Assessing Germline Transmission Risk and First-in-Human Dose Selection for In Vivo Gene Therapies
- A dual-function adenoviral system for transgene delivery and gene editing for host factor studies in a murine model of SARS-CoV-2 infection
- A Novel Human iPSC-derived Liver Model for In Vitro Assessment of AAV Gene Therapies
- Cryo-EM Mapping of Human Neutralizing Antibodies Reveals 3-fold Antigenic “Hotspot” on the AAV2 Capsid
- Validation of an agonistic canine anti-CD3ε antibody for the production of metabolically fit T cells for adoptive therapy